CPD Article: New therapies in schizophrenia.

  • S Brink Consultant, Stikland Hospital. Lecturer,Department of Psychiatry, University of Stellenbosch.

Abstract

Schizophrenia is a serious, chronic illness of the brain that affects approximately 1% of the general population. In the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) schizophrenia is described as “a disturbance that lasts for at least 6 months and includes at least a month of active-phase symptoms (that is, two or more of the following: delusions, hallucinations, disorganised speech, grossly disorganised or catatonic behavior, negative symptoms). (SA Fam Pract 2004;46(4): 16-18)

Author Biography

S Brink, Consultant, Stikland Hospital. Lecturer,Department of Psychiatry, University of Stellenbosch.
MBChB,MMed, FCPsych.
Published
2004-05-01
Issue
Vol 46, No 4 - May 2004
Section
Review Articles
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.